38
Views
0
CrossRef citations to date
0
Altmetric
Supplement

Foreword

Pages 1-2 | Received 08 Sep 2017, Accepted 19 Sep 2017, Published online: 16 Nov 2017
 

Financial & competing interests disclosure

R Linker has received compensation for activities with, or research support from, Almirall, Bayer Healthcare, Biogen, Fresenius, Genzyme, Merck, Novartis, Roche and Teva. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Writing assistance was provided by Content Ed Net (Madrid, Spain), with funding from Almirall SA (Barcelona, Spain).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.